These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32024714)

  • 41. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation.
    Borck G; Beighton P; Wilhelm C; Kohlhase J; Kubisch C
    Am J Med Genet A; 2010 Aug; 152A(8):2090-3. PubMed ID: 20635400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arterial complications in classical Ehlers-Danlos syndrome: a case series.
    Angwin C; Brady AF; Pope FM; Vandersteen A; Baker D; Cheema H; Sobey G; Johnson D; von Klemperer K; Kazkaz H; van Dijk F; Ghali N
    J Med Genet; 2020 Nov; 57(11):769-776. PubMed ID: 32467296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized Hyperalgesia in Children and Adults Diagnosed With Hypermobility Syndrome and Ehlers-Danlos Syndrome Hypermobility Type: A Discriminative Analysis.
    Scheper MC; Pacey V; Rombaut L; Adams RD; Tofts L; Calders P; Nicholson LL; Engelbert RH
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):421-429. PubMed ID: 27483212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.
    Ritelli M; Dordoni C; Venturini M; Chiarelli N; Quinzani S; Traversa M; Zoppi N; Vascellaro A; Wischmeijer A; Manfredini E; Garavelli L; Calzavara-Pinton P; Colombi M
    Orphanet J Rare Dis; 2013 Apr; 8():58. PubMed ID: 23587214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multifaceted and complex hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome Hypermobility Type): evaluation and management through a rehabilitative approach.
    Celletti C; Camerota F
    Clin Ter; 2013; 164(4):e325-35. PubMed ID: 24045532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ehlers-Danlos syndrome-related genes and serum strontium, zinc, and lithium levels in generalized joint hypermobility: a case-control study.
    Tuna F; Doğanlar ZB; Özdemir H; Demirbag Kabayel D; Doğanlar O
    Connect Tissue Res; 2021 Mar; 62(2):215-225. PubMed ID: 31594391
    [No Abstract]   [Full Text] [Related]  

  • 47. Entrapment neuropathies and polyneuropathies in joint hypermobility syndrome/Ehlers-Danlos syndrome.
    Granata G; Padua L; Celletti C; Castori M; Saraceni VM; Camerota F
    Clin Neurophysiol; 2013 Aug; 124(8):1689-94. PubMed ID: 23743406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Morlino S; Celletti C; Ghibellini G; Bruschini M; Grammatico P; Blundo C; Camerota F
    Am J Med Genet A; 2013 Dec; 161A(12):2989-3004. PubMed ID: 24254847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised.
    Sinibaldi L; Ursini G; Castori M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):97-106. PubMed ID: 25821094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ehlers-Danlos syndrome].
    Leganger J; Søborg ML; Farholt S; Lund AM; Rosenberg J; Burcharth J
    Ugeskr Laeger; 2016 Apr; 178(17):. PubMed ID: 27136954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral manifestations of Ehlers-Danlos syndrome.
    Létourneau Y; Pérusse R; Buithieu H
    J Can Dent Assoc; 2001 Jun; 67(6):330-4. PubMed ID: 11450296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Difficulty eating and significant weight loss in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Baeza-Velasco C; Van den Bossche T; Grossin D; Hamonet C
    Eat Weight Disord; 2016 Jun; 21(2):175-83. PubMed ID: 26506923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ehlers-Danlos syndrome coexisting with juvenile nephronophtisis.
    Tarrass F; Benjelloun M; Hachim K; Benghanem MG; Ramdani B; Zaid D; Benkirane A; Sqalli S
    Nephrology (Carlton); 2006 Apr; 11(2):117-9. PubMed ID: 16669972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers-Danlos syndrome, hypermobility type.
    Puledda F; Viganò A; Celletti C; Petolicchio B; Toscano M; Vicenzini E; Castori M; Laudani G; Valente D; Camerota F; Di Piero V
    Neurol Sci; 2015 Aug; 36(8):1417-24. PubMed ID: 25791889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unexpected association between joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type and obsessive-compulsive personality disorder.
    Pasquini M; Celletti C; Berardelli I; Roselli V; Mastroeni S; Castori M; Biondi M; Camerota F
    Rheumatol Int; 2014 May; 34(5):631-6. PubMed ID: 24272065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular genetics in classic Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Joint hypermobility: emerging disease or illness behaviour?
    Grahame R
    Clin Med (Lond); 2013 Dec; 13 Suppl 6():s50-2. PubMed ID: 24298184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome.
    Boris JR; Bernadzikowski T
    Auton Neurosci; 2021 Mar; 231():102770. PubMed ID: 33388686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Chohan K; Mittal N; McGillis L; Lopez-Hernandez L; Camacho E; Rachinsky M; Mina DS; Reid WD; Ryan CM; Champagne KA; Orchanian-Cheff A; Clarke H; Rozenberg D
    Chron Respir Dis; 2021; 18():14799731211025313. PubMed ID: 34291699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.